Company / Net Income
AMICUS THERAPEUTICS, INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$27.1M
FY2025
5-year range
-$250.5M / -$27.1M
FY2021-FY2025
Trend
+51.7%
vs FY2024
Sector context
#75 of 216
Health Care
What the data says
At -$27M, AMICUS THERAPEUTICS, INC.'s net income ranks #75 of 216 in the Health Care sector. Net Income has increased for 6 consecutive years, from -$356M in FY2019 to -$27M in FY2025.
Based on SEC 10-K filings.
-$27M in FY2025.
Improved from -$152M to -$27M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#75 of 216 in Health CareTop 35% of 216This company -$27.1M Sector average $454.3M
▼
-106.0% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s net income has grown for 6 consecutive years.
- In FY2025, net income increased 51.7% year-over-year.
- Ranks #75 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$27.1M | +51.7% |
| FY2024 | -$56.1M | +63.0% |
| FY2023 | -$151.6M | +35.9% |
| FY2022 | -$236.6M | +5.5% |
| FY2021 | -$250.5M | +9.5% |
| FY2020 | -$276.9M | +22.3% |
| FY2019 | -$356.4M | -2.1% |
| FY2018 | -$349.0M | -22.9% |
| FY2017 | -$284.0M | -42.0% |
| FY2016 | -$200.0M | -51.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026